Wall Street Analyst Action: Omnicell, Idenix, Kirby Corp, Sunoco, Constant Contact
Omnicell Inc.(NASDAQ:OMCL): Piper Jaffray views CareFusion’s (NYSE:CFN) commentary about strength in the dispensing units market as positive for Omnicell (NASDAQ:OMCL) and Cerner (NASDAQ:CERN). Piper sees potential upside to Omnicell’s 2012 guidance and has increased confidence in Cerner’s results. The firm maintains Overweight ratings on both Omnicell and Cerner.
Idenix Pharmaceuticals Inc.(NASDAQ:IDIX): William Blair raised its probability that IDX184 reaches the market to 81% from 59% and increased its peak worldwide sales estimate to $1.3B from $1B. Shares are Outperform rated.
Kirby Corporation(NYSE:KEX): Cantor increased its target on Kirby after the company reported in;line Q4 EPS and provided in-line FY12 EPS guidance. The firm believes that Kirby is continuing to benefit from higher demand and utilization levels, and it maintains a Buy rating.
Sunoco Inc.(NYSE:SUN): Sunoco named a long Research Tactical Idea at Morgan Stanley
Constant Contact, Inc.(NASDAQ:CTCT): Barrington raised its target on Constant Contact after the company reported stronger than expected Q4 results. The firm believes that the company;’s new social tool and its expansion in the U.K. could allow it to beat expectations going forward, and it continues to include the stock in its Best Ideas List.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org